By: 29 February 2012

A new study by industry analysts Plimsoll Publishing has identified a group of 52 emerging companies in the UK Orthopaedic Equipment industry. In the last year these companies have increased sales by an average 14% and are taking further control of the market as we start 2012.

Over the last two years, growth in the market has been sporadic, averaging 3% two years ago and 1% last year. However, these high growth companies have managed to grow much faster. The following table highlights how they are grabbing market share at the expense of the rest:

Of the 549 companies analysed in the just published Plimsoll Analysis, 55 were found to be suffering the consequences of these high growth companies. They saw their own sales fall, on average by -8% in the same period. David Pattison, author of this new market study states: “This is absolute evidence that whatever growth there is in the market is being captured by a select group of companies.”

So what have these companies been doing to create this growth? Pattison offers the following explanation: “It’s clear that the market is changing. The revenue and growth streams companies took for granted a couple of years ago have changed. Frankly, it’s the one question that we all want to know the answer to, “Where is the market heading?”. These 52 winning companies seem to have the best idea.”

Despite concerns to the contrary, this is not just a case of larger companies forcing out their smaller competitors. As the following table shows, growth is still being achieved by a number of small. Innovative companies (as well as some of the majors):

The new Plimsoll Analysis provides a full financial analysis on the Top 549 companies in the UK Orthopaedic Equipment industry. Their full financial performance over the last 4 years is presented in the publication. The analysis is designed for the busy manager who needs to spot trends in the overall market, identify and understand threatening competitors. For those looking for quick growth, the analysis can also be used to seek out acquisition prospects.

Copies of the full 549 paged analysis are available now in PDF format, priced at £350 (+VAT). We would be delighted to offer readers of Orthopaedic Product News a £50 discount if they quote reference PR/AA10

Contact Christopher Evans at or visit for more information.

Junior editor at Fintech Intel